Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Therapy (Alone or in Combination) or Radiotherapy on the Primary Tumor in Combination With Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: Multicenter Observational Study of Patients Undergoing Treatment in Clinical Practice in Italian Hospitals

NCT06473259 is registered in ClinicalTrials.gov with Santa Chiara Hospital as lead sponsor.

NCT NCT06473259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06473259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Therapy (Alone or in Combination) or Radiotherapy on the Primary Tumor in Combination With Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: Multicenter Observational Study of Patients Undergoing Treatment in Clinical Practice in Italian Hospitals
Lead sponsor
Santa Chiara Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 16, 2016
Completion date
December 31, 2028
Enrollment
3,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hormone sensitive prostate cancer, metastatic tumor, prostate cancer